Uray - IoT urinalysis solution

Uray is a game-changing urinalysis platform that utilizes photonics and AI technologies to revolutionize urine analysis. The reagent-free handheld real-time urine analyzer provides comprehensive test results within 10 seconds with laboratory accuracy. This MedTech Startup, Uray, founded in 2021 and headquartered in Singapore, aims to prevent chronic kidney disease, urolithiasis disease, urinary tract infections, abnormal pregnancy, and more. The handheld device, synchronized with a mobile application via Wi-Fi, allows for remote test result reception and collection. Uray's solution is non-invasive, reagent-free, and adopts disposable urine containers for convenient use. It also enables longitudinal health monitoring and detection of 20 biomarkers, promising a comprehensive health analysis from a single urine sample. Uray is seeking cooperation with nephrology communities, practicing nephrologists, medical experts, and centers to validate their technology and perform clinical trials. In addition, they are looking for investment to transition from prototype to series production, obtain medical registration, and initiate pilot sales in Singapore. The startup has already secured a $140.00K Pre Seed Round investment on 15 July 2021 to support its innovative healthcare technology. With a team of experts in photonics, machine learning, hardware development, and medical device marketing and sales, Uray has completed the proof of concept stage and is nearing the completion of the Minimum Viable Product, with plans to test a small batch of devices in clinics.